Myriam Perrotta

Hospital Italiano de Buenos Aires

Papers

2

Total Citations

114

H-Index

2

About

Dr. Myriam Perrotta is a leading gynecologic oncologist whose research has fundamentally advanced the surgical management of early-stage cervical cancer, particularly for young women seeking fertility preservation. Her primary contributions center on radical trachelectomy, a fertility-sparing alternative to radical hysterectomy. Through the landmark International Radical Trachelectomy Assessment Study (IRTA), Dr. Perrotta led a global effort comparing open versus minimally invasive surgical approaches, producing findings that have directly shaped clinical guidelines and patient counseling worldwide. Her work, cited over 100 times collectively, provides critical evidence on oncologic outcomes and surgical safety, helping to refine patient selection and operative technique. Dr. Perrotta’s research is notable for its international, collaborative design, bringing together data from multiple centers to generate robust, practice-changing conclusions. By systematically evaluating the trade-offs between surgical approaches, she has empowered surgeons and patients to make informed decisions that balance cancer control with quality of life. Her studies remain essential reading for any clinician or researcher working in gynecologic oncology, fertility preservation, or minimally invasive surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
114
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study
61 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 39
🏛 Institutions: Hospital Italiano de Buenos Aires

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago